AIM
EIGR

Axiom Investment Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Axiom Investment Management’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-33
Closed -$8K – 465
2022
Q3 		$8K Buy
+33
New +$8K 0.02% 271